Literature DB >> 8034039

Free insulin-like growth factors (IGF-I and IGF-II) in human serum.

J Frystyk1, C Skjaerbaek, B Dinesen, H Orskov.   

Abstract

Using ultrafiltration by centrifugation we have isolated the free, unbound fractions of insulin-like growth factor I and II (free IGF-I and IGF-II) in human serum. In this way near in vivo conditions could be maintained before and during isolation. The recovery was 80 to 100% in the ultrafiltrates, which contained no detectable amounts of IGF-binding proteins (IGFBPs) as measured by Western ligand blotting and IGFBP-1 and IGFBP-3 immunoassays. The concentration of free peptides was measured in two ultrasensitive non-competitive IGF-I and IGF-II time-resolved fluoroimmunoassays. We found that (i) equilibrium between free and protein-complexed IGF was strongly dependent on re-establishment of in vivo conditions (temperature, pH, ionic milieu and dilution); (ii) metabolic events (glucose load and fasting) caused significant changes in free IGF-I and IGF-II levels without concomitant changes in total circulating levels of IGFs; (iii) in 49 healthy adult subjects (20 to above 60 years) free IGF-I was inversely related to age and ranged from 950 +/- 150 ng/l (mean +/- S.E.M.) (20-30 years) to 410 +/- 70 ng/l (> 60 years). The relative percentage was, however, unchanged, being 0.38 +/- 0.02% of total IGF-I. In contrast, free IGF-II was independent of age, being 1,480 +/- 80 ng/l (approximately 0.20 +/- 0.01% of total IGF-II).

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8034039     DOI: 10.1016/0014-5793(94)00602-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  31 in total

1.  Is the measurement of free IGF-I more indicative than that of total IGF-I in the evaluation of the biological activity of the GH/IGF-I axis?

Authors:  J A Janssen; S W Lamberts
Journal:  J Endocrinol Invest       Date:  1999-04       Impact factor: 4.256

2.  Bioactivity of glomerular ultrafiltrate during heavy proteinuria may contribute to renal tubulo-interstitial lesions: evidence for a role for insulin-like growth factor I.

Authors:  R Hirschberg
Journal:  J Clin Invest       Date:  1996-07-01       Impact factor: 14.808

3.  Testosterone and estradiol regulate free insulin-like growth factor I (IGF-I), IGF binding protein 1 (IGFBP-1), and dimeric IGF-I/IGFBP-1 concentrations.

Authors:  Johannes D Veldhuis; Jan Frystyk; Ali Iranmanesh; Hans Ørskov
Journal:  J Clin Endocrinol Metab       Date:  2005-02-15       Impact factor: 5.958

Review 4.  General aspects of insulin-like growth factor binding proteins.

Authors:  K Chan; E M Spencer
Journal:  Endocrine       Date:  1997-08       Impact factor: 3.633

Review 5.  Insulin-Like growth factor I: implications in aging.

Authors:  E Arvat; F Broglio; E Ghigo
Journal:  Drugs Aging       Date:  2000-01       Impact factor: 3.923

6.  Expression and function of receptors for insulin-like growth factor-I and insulin in human coronary artery smooth muscle cells.

Authors:  S I Chisalita; H J Arnqvist
Journal:  Diabetologia       Date:  2005-08-11       Impact factor: 10.122

Review 7.  Delivery of neurotrophic factors to the central nervous system: pharmacokinetic considerations.

Authors:  R G Thorne; W H Frey
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 8.  Insulin-like growth factor 1 physiology: lessons from mouse models.

Authors:  Shoshana Yakar; Martin L Adamo
Journal:  Endocrinol Metab Clin North Am       Date:  2012-05-15       Impact factor: 4.741

9.  Bioactive insulin-like growth factor-I in obesity.

Authors:  J Frystyk; D J Brick; A V Gerweck; A L Utz; K K Miller
Journal:  J Clin Endocrinol Metab       Date:  2009-05-26       Impact factor: 5.958

10.  Effects of oral contraceptives on diurnal profiles of insulin, insulin-like growth factor binding protein-1, growth hormone and cortisol in endurance athletes with menstrual disturbance.

Authors:  A Rickenlund; M Thorén; A Nybacka; J Frystyk; A Lindén Hirschberg
Journal:  Hum Reprod       Date:  2009-10-19       Impact factor: 6.918

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.